How does adenosine control neuronal dysfunction and neurodegeneration?
RA Cunha - Journal of neurochemistry, 2016 - Wiley Online Library
The adenosine modulation system mostly operates through inhibitory A1 (A1R) and
facilitatory A2A receptors (A2AR) in the brain. The activity‐dependent release of adenosine …
facilitatory A2A receptors (A2AR) in the brain. The activity‐dependent release of adenosine …
Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology
JD Salamone, SE Yohn, L López-Cruz, N San Miguel… - Brain, 2016 - academic.oup.com
Motivation has been defined as the process that allows organisms to regulate their internal
and external environment, and control the probability, proximity and availability of stimuli. As …
and external environment, and control the probability, proximity and availability of stimuli. As …
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors—an update
BB Fredholm, AP IJzerman, KA Jacobson… - Pharmacological …, 2011 - ASPET
In the 10 years since our previous International Union of Basic and Clinical Pharmacology
report on the nomenclature and classification of adenosine receptors, no developments …
report on the nomenclature and classification of adenosine receptors, no developments …
International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors
BB Fredholm, AP IJzerman, KA Jacobson… - Pharmacological …, 2001 - ASPET
Four adenosine receptors have been cloned and characterized from several mammalian
species. The receptors are named adenosine A1, A2A, A2B, and A3. The A2A and A2B …
species. The receptors are named adenosine A1, A2A, A2B, and A3. The A2A and A2B …
Adenosine receptors as therapeutic targets
KA Jacobson, ZG Gao - Nature reviews Drug discovery, 2006 - nature.com
Adenosine receptors are major targets of caffeine, the most commonly consumed drug in the
world. There is growing evidence that they could also be promising therapeutic targets in a …
world. There is growing evidence that they could also be promising therapeutic targets in a …
[HTML][HTML] Sleep and circadian rhythms in Parkinson's disease and preclinical models
The use of animals as models of human physiology is, and has been for many years, an
indispensable tool for understanding the mechanisms of human disease. In Parkinson's …
indispensable tool for understanding the mechanisms of human disease. In Parkinson's …
Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits
Background Over the last several years, it has become apparent that there are critical
problems with the hypothesis that brain dopamine (DA) systems, particularly in the nucleus …
problems with the hypothesis that brain dopamine (DA) systems, particularly in the nucleus …
[HTML][HTML] Slow-wave sleep is controlled by a subset of nucleus accumbens core neurons in mice
Y Oishi, Q Xu, L Wang, BJ Zhang, K Takahashi… - Nature …, 2017 - nature.com
Sleep control is ascribed to a two-process model, a widely accepted concept that posits
homoeostatic drive and a circadian process as the major sleep-regulating factors. Cognitive …
homoeostatic drive and a circadian process as the major sleep-regulating factors. Cognitive …
The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA,“ecstasy”)
AR Green, AO Mechan, JM Elliott, E O'Shea… - Pharmacological …, 2003 - ASPET
The amphetamine derivative (±)-3, 4-methylenedioxymethamphetamine (MDMA, ecstasy) is
a popular recreational drug among young people, particularly those involved in the dance …
a popular recreational drug among young people, particularly those involved in the dance …
Purinergic signalling: from normal behaviour to pathological brain function
G Burnstock, U Krügel, MP Abbracchio, P Illes - Progress in neurobiology, 2011 - Elsevier
Purinergic neurotransmission, involving release of ATP as an efferent neurotransmitter was
first proposed in 1972. Later, ATP was recognised as a cotransmitter in peripheral nerves …
first proposed in 1972. Later, ATP was recognised as a cotransmitter in peripheral nerves …